VC
BPMC

Veracity Capital’s Blueprint Medicines BPMC Stock Holding History

Veracity Capital’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,114
Closed -$548K – 235
2021
Q4 		$548K Sell
5,114
-1,000
-16% -$105K 0.22% 112
2021
Q3 		$629K Hold
6,114
– – 0.27% 95
2021
Q2 		$538K Sell
6,114
-6,102
-50% -$559K 0.12% 141
2021
Q1 		$1.19M Hold
12,216
– – 0.25% 106
2020
Q4 		$1.37M Sell
12,216
-8,000
-40% -$843K 0.34% 90
2020
Q3 		$1.87M Hold
20,216
– – 0.51% 63
2020
Q2 		$1.58M Buy
20,216
+14
+0.1% +$947 0.44% 68
2020
Q1 		$1.18M Hold
20,202
– – 0.34% 66
2019
Q4 		$1.62M Buy
+20,202
New +$1.51M 0.42% 72

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Veracity Capital's BPMC Position: Q1 2022 in Review

Veracity Capital sold out of Blueprint Medicines (BPMC) in Q1 2022, closing a stake of 5,114 shares — an estimated $548K sold.

Veracity Capital first reported a position in BPMC in Q4 2019 and held it in 9 quarters. The position peaked at $1.87M in Q3 2020. 248 funds tracked by Wall St. Rank hold BPMC as of Q1 2022.

  • Veracity Capital reported no remaining Blueprint Medicines position as of Q1 2022 after selling out during the quarter.
  • Veracity Capital sold 5,114 Blueprint Medicines shares in Q1 2022, an estimated $548K.
  • Veracity Capital first reported a position in Blueprint Medicines in Q4 2019 and held it in 9 quarters.
  • Veracity Capital's Blueprint Medicines position peaked at $1.87M in Q3 2020.
  • 248 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2022.

Based on Veracity Capital's 13F filing for Q1 2022, filed 18 Apr 2022.